Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

Video Expert Opinion

Colleague Insights

Conferences

Published in Multiple Sclerosis and

Journal Scan / Research · April 04, 2024

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections

Neurology(R) Neuroimmunology & Neuroinflammation

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

Neurology(R) Neuroimmunology & Neuroinflammation

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections

Neurol Neuroimmunol Neuroinflamm 2024 May 01;11(3)e200211, A Langer-Gould, BH Li, JB Smith, S Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users